compulsory patent licensing india
Asia Pacific Laws, Biosimilars, Biosimilars and Biologics, Biotech Patents, Biotechnology Patents, Intellectual Property Rights Protection, Laws - Intellectual Property Rights, patent attorney india, Patent Publications - Technology, Business and Law, patent services, Patents, Patents Granted by Patent Office, Pharmaceutical Patents

BioSpectrum Asia – Compulsory License of Bayer’s Nexavar

BioSpectrum Asia - Debate over compulsory licensing of Bayer's Nexavar  Originally published here. Full Article: India allows compulsory licensing of Bayer’s Nexavar In March 2012, the Indian Patent office granted first compulsory license to NATCO pharma to make anti-cancer drug sorafenib for the India market. However, the compulsory license is subject to certain conditions, such… Continue reading BioSpectrum Asia – Compulsory License of Bayer’s Nexavar

Advertisements
biotech plant seed patent india
Biotech Patents, Biotechnology Patents, Intellectual Property Rights Protection, Laws - Intellectual Property Rights, patent attorney india, Patent Lawyer Patent Attorney Consulting, Patent Publications - Technology, Business and Law, patent services, Patents, Patents Granted by Patent Office

Economic Times – Monsanto’s Climate Resilient Crop Patent Rejection

Views published in Economic Times regarding Monsanto’s patent rejection order passed by Intellectual Property Appellate Board (IPAB). Full Article - Monsanto’s Cimate-resilient Crop Patent Claims Rejected Full copy of IPAB Order. Originally published here. Monsanto filed patent application No.2407/DEL/NP/2006 on 01/05/2006. The patent office examined the claimed subject matter and raised objections on various grounds specified… Continue reading Economic Times – Monsanto’s Climate Resilient Crop Patent Rejection

pre grant post grant patent opposition lawyer attorney law firm
Biosimilars, Biosimilars and Biologics, Biotech Patents, Biotechnology Patents, Intellectual Property Rights Protection, Laws - Intellectual Property Rights, patent attorney india, Patent Lawyer Patent Attorney Consulting, Patent Publications - Technology, Business and Law, patent services, Patents, Patents Granted by Patent Office, Pharmaceutical Patents

LawAsia Publication – Patent Opposition in India

Full Article: Patent Opposition in India: Recent Trends Overview of patent opposition in India, the two-stage patent opposition process and how it affects the industry, as the patent applicants are now vulnerable to multiple pre-grant oppositions filed by competitors, or even by a single competitor, since there is nothing to stop a party which has filed a pre-grant… Continue reading LawAsia Publication – Patent Opposition in India

patent attorney asia china india malaysia singapore
Asia Pacific Laws, Biosimilars, Biosimilars and Biologics, Biotech Patents, Biotechnology Patents, Corporate Governance and Regulatory Compliance, Incorporating New Business, Intellectual Property Rights Protection, Laws - Intellectual Property Rights, News, patent attorney india, Patent Lawyer Patent Attorney Consulting, Patent Publications - Technology, Business and Law, patent services, Patents, Pharmaceutical Patents

BioSpectrum – Regulatory Challenges For APAC Businesses – Biotech in Asia Pacific

By 2020, according to Frost & Sullivan, healthcare expenditure in the APAC will increase 151 percent over 2010 figure, to $2927 billion at a compound annual growth rate of 9.2 percent. Factors such as increasing population, per capita income, prevalence of lifestyle diseases due to rapid urbanization, apart from cost factors, are aiding growth. However,… Continue reading BioSpectrum – Regulatory Challenges For APAC Businesses – Biotech in Asia Pacific

patent filing in india
Biotechnology Patents, Corporate Governance and Regulatory Compliance, Intellectual Property Rights Protection, Laws - Intellectual Property Rights, News, patent attorney india, Patent Lawyer Patent Attorney Consulting, Patent Publications - Technology, Business and Law, patent services, Patents, Patents Granted by Patent Office, Pharmaceutical Patents

Global Legal Post – Indian Patent Office Backlog

Global Legal Post Publication Before US visit, PM Modi announced to resolve one the most crucial issues daunting the Indian Patent Office, i.e. clearing the huge backlog. Originally published here. Full Article: 1,000 backlog beaters for Indian patent office Rahul Dev, Partner at the law firm of Tech Corp Legal LLP, is a patent attorney and international… Continue reading Global Legal Post – Indian Patent Office Backlog

pharma patent attorney
Biotechnology Patents, Intellectual Property Rights Protection, Law for Offline Startups, Laws - Intellectual Property Rights, patent attorney india, Patent Lawyer Patent Attorney Consulting, Patent Publications - Technology, Business and Law, patent services, Patents, Patents Granted by Patent Office, Pharmaceutical Patents

Swissinfo – Novartis Patent Case – Indacaterol – Onbrez Delhi High Court Judgement

Swissinfo is Swiss Government's International Publication Service managed by Swiss Broadcasting Corporation (SBC). Originally published here. Views on Delhi High Court's ruling in Novartis patent dispute: "the ruling is totally in line with existing laws, rules and judicial precedents. For example, the Indian patents act provides provisions for revocation of patent rights in case such… Continue reading Swissinfo – Novartis Patent Case – Indacaterol – Onbrez Delhi High Court Judgement

biosimilar biotech patent attorney
Biosimilars, Biosimilars and Biologics, Biotechnology Patents, Industry News - Technology, Business and Law, patent attorney india, Patent Lawyer Patent Attorney Consulting, Pharmaceutical Patents

Regulatory Challenges and FDA Approval of Biosimilars – An Overview

Biosimilars are generic versions of biologics, medicinal products with active drug component being made (or derived) from a living organism. It is complicated and cost intensive to manufacture biologics, and hence regulatory approval of biosimilars is very challenging. Originally published here. //storify.com/rdpatentlawyer/fda-approval-of-biosimilars-regulatory-challenges/embed//storify.com/rdpatentlawyer/fda-approval-of-biosimilars-regulatory-challenges.js[View the story "FDA Approval of Biosimilars - Regulatory Challenges" on Storify] About the… Continue reading Regulatory Challenges and FDA Approval of Biosimilars – An Overview